China Construction Bank Corporation (00939): Yang Qiang appointed as Independent Non-Executive Director
China Construction Bank (00939) announced that on June 26, 2026, the shareholders' meeting of China Construction Bank Corporation (the Bank) approved the proposal to elect Mr. Yang Qiang as an independent non-executive director of the Bank for the 2025 fiscal year. The National Financial Regulatory Administration has now approved Mr. Yang Qiang's qualification for the position, and Mr. Yang Qiang has officially assumed the role of independent non-executive director of the Bank.
China Construction Bank Corporation (00939) announced that on June 26, 2026, the 2025 Annual General Meeting of Shareholders of China Construction Bank Corporation (the Bank) passed the proposal to elect Mr. Yang Qiang as an independent non-executive director of the Bank. The National Financial Regulatory Administration has now approved Mr. Yang Qiang's qualifications for the position, and Mr. Yang Qiang has officially assumed the role of independent non-executive director of the Bank.
Related Articles
Ever Harvest GP (01549) released its interim results, with a net profit of HK$783,000, a decrease of 89.8% year-on-year.
R&F PROPERTIES (02777) announced its interim results, with a loss attributable to shareholders of 5.268 billion yuan, an increase of 30.2% year-on-year.
Biocytogen Pharmaceuticals (02315) accelerates its path towards high-quality development with both revenue and net profit soaring.
Ever Harvest GP (01549) released its interim results, with a net profit of HK$783,000, a decrease of 89.8% year-on-year.
R&F PROPERTIES (02777) announced its interim results, with a loss attributable to shareholders of 5.268 billion yuan, an increase of 30.2% year-on-year.
Biocytogen Pharmaceuticals (02315) accelerates its path towards high-quality development with both revenue and net profit soaring.
RECOMMEND
